%0 Generic %A Dieter, Cristine %A Assmann, Taís Silveira %A Costa, Aline Rodrigues %A Canani, Luís Henrique %A de Souza, Bianca Marmontel %A Bauer, Andrea Carla %A Crispim, Daisy %D 2019 %T Table_1_MiR-30e-5p and MiR-15a-5p Expressions in Plasma and Urine of Type 1 Diabetic Patients With Diabetic Kidney Disease.XLS %U https://frontiersin.figshare.com/articles/dataset/Table_1_MiR-30e-5p_and_MiR-15a-5p_Expressions_in_Plasma_and_Urine_of_Type_1_Diabetic_Patients_With_Diabetic_Kidney_Disease_XLS/8262476 %R 10.3389/fgene.2019.00563.s003 %2 https://frontiersin.figshare.com/ndownloader/files/15448958 %K microRNA expression %K miR-15a-5p %K miR-30e-5p %K diabetic kidney disease %K bioinformatics analysis %K type 1 diabetes mellitus %X Introduction

Diabetic kidney disease (DKD) is a common microvascular complication that affects 40% of patients with diabetes mellitus (DM). Emerging evidence suggests a role for several microRNAs (miRNAs) in the development of DKD. In this context, miR-15a-5p and miR-30e-5p have been shown to regulate the expression of the uncoupling protein 2 (UCP2), a mitochondrial protein that decreases reactive oxygen species (ROS) formation by the mitochondria. Since ROS overproduction is a key contributor to the pathogenesis of DKD, dysregulation of these two miRNAs could be involved in DKD pathogenesis. Thus, the aim of this study was to compare the expressions of miR-15a-5p and miR-30e-5p in type 1 DM (T1DM) patients with DKD (cases) and without this complication (controls), and to perform bioinformatics analyses to investigate their putative targets and biological pathways under their regulation.

Methods

MiR-15a-5p and miR-30e-5p expressions were analyzed in plasma and urine of 17 T1DM controls and 23 DKD cases (12 with moderate DKD and 11 with severe DKD) using qPCR. Bioinformatics analyses were performed in Cytoscape software.

Results

MiR-30e-5p expression was downregulated in plasma of patients with moderate and severe DKD compared to T1DM controls. Moreover, this miRNA was also downregulated in urine of patients with severe DKD compared to the other groups. No difference was found in miR-15a-5p expression between groups. Bioinformatics analyses indicated that miR-30e-5p and miR-15a-5p regulate various genes that participate in pathways related to angiogenesis, apoptosis, cell differentiation, oxidative stress, and hypoxia.

Conclusion

MiR-30e-5p seems to be downregulated in plasma and urine of patients with DKD.

%I Frontiers